QGEN
Companies
Nyse American
Qiagen N.V.
Health Care
$46.55
+$2.24 (+5.03%)
Price Chart
Overview
About QGEN
Qiagen NV offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
Market Cap
$9.9B
Volume
71.0M
Avg. Volume
57.6M
P/E Ratio
16.9476
Dividend Yield
0.00%
Employees
5.5K
Company Information
Risk & Correlation Analysis
Market Correlation
0.37
Low Correlation
Volatility
Medium (0.23)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, QGEN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$9.9B
Volume71.0M
P/E Ratio16.95
Dividend Yield0.00%
Important Dates
Next Dividend
January 29, 2025Next Earnings
February 6, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025